← SynDRA
FORODESINE
SynDRA canonical compound SYN0006371 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Primary target(s) | PNP |
| Mechanism of action | purinergic receptor antagonist |
| Indication | peripheral T-cell lymphoma (PTCL) |
| Disease area | hematologic malignancy |
All known targets
Mechanisms of action (all sources)
- PNP INHIBITOR
- Purine nucleoside phosphorylase inhibitor
- purinergic receptor antagonist
Cross-references
Synonyms
- forodesine hydrochloride
- forodesine HCl
- mundesine
- fodosine
- BCX-1777
- Immucillin H
- Forodesina
- Immucillin h
- Mundesine
- NSC-717904
- Fodosine
- Immucillin-H
- 1,4-dideoxy-4-aza-1-(s)-(9-deazahypoxanthin-9-yl)-d-ribitol
- UNII-426X066ELK
- CHEMBL218291
- CHEBI:43362
- 426X066ELK
- (1S)-1,4-dideoxy-4-imino-(9-deazahypoxanthin-9-yl)-D-ribitol
- IMH
- 7-[(2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1,5-dihydro-4H-pyrrolo[3,2-d]pyrimidin-4-one
- (2R,3R,4S,5S)-2-(hydroxymethyl)-5-(4-hydroxy-5H-pyrrolo[3,2-d]pyrimidin-7-yl)pyrrolidine-3,4-diol
- Fodosine (TN)
- BCX 1777
- 5(S),12(S)-diHETE
- BCX1777
- 7-[(2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1,5-dihydropyrrolo[3,2-d]pyrimidin-4-one
- NSC 717904
- ImmH cpd
- 4H-Pyrrolo(3,2-d)pyrimidin-4-one, 7-((2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-pyrrolidinyl)-1,5-dihydro-
- 7-((2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl)-3H-pyrrolo[3,2-d]pyrimidin-4(5H)-one
- Forodesine (USAN/INN)
- (-)-7-((2S,3S,4R,5R)-3,4-Dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl)-1,5-dihydro-4H-pyrrolo(3,2-d)pyrimidin-4-one
- (-)-7-[(2S,3S,4R,5R)-3,4-Dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1,5-dihydro-4H-pyrrolo[3,2-d]pyrimidin-4-one
- 7-((2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl)-3,5-dihydro-4H-pyrrolo[3,2-d]pyrimidin-4-one
- 7-[(2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-3,5-dihydro-4H-pyrrolo[3,2-d]pyrimidin-4-one
- 1-(9-deazahypoxanthin-9-yl)-1,4-dideoxy-1,4-iminoribitol
- 1b8o
- 1g2o
Look up FORODESINE in the interactive SynDRA portal →